Concurrent cryptococcal meningitis and falciparum malaria in a child with nephrotic syndrome. 1998

B R Mirdha, and T Sarkar, and U Banerjee, and S Sethi, and G Dan, and I Xess
Department of Microbiology, All India Institute of Medical Sciences, New Delhi.

UI MeSH Term Description Entries
D008297 Male Males
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D016778 Malaria, Falciparum Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations. Plasmodium falciparum Malaria,Malaria, Plasmodium falciparum
D016919 Meningitis, Cryptococcal Meningeal inflammation produced by CRYPTOCOCCUS NEOFORMANS, an encapsulated yeast that tends to infect individuals with ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunocompromised states. The organism enters the body through the respiratory tract, but symptomatic infections are usually limited to the lungs and nervous system. The organism may also produce parenchymal brain lesions (torulomas). Clinically, the course is subacute and may feature HEADACHE; NAUSEA; PHOTOPHOBIA; focal neurologic deficits; SEIZURES; cranial neuropathies; and HYDROCEPHALUS. (From Adams et al., Principles of Neurology, 6th ed, pp721-2) Cryptococcal Meningitis,Granulomous Cerebral Cryptococcosis,Toruloma,Cerebral Cryptococcosis,Cerebral Cryptococcoses,Cerebral Cryptococcoses, Granulomous,Cerebral Cryptococcosis, Granulomous,Cryptococcal Meningitides,Cryptococcoses, Cerebral,Cryptococcoses, Granulomous Cerebral,Cryptococcosis, Cerebral,Cryptococcosis, Granulomous Cerebral,Granulomous Cerebral Cryptococcoses,Meningitides, Cryptococcal,Torulomas

Related Publications

B R Mirdha, and T Sarkar, and U Banerjee, and S Sethi, and G Dan, and I Xess
July 2011, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine,
B R Mirdha, and T Sarkar, and U Banerjee, and S Sethi, and G Dan, and I Xess
July 1970, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
B R Mirdha, and T Sarkar, and U Banerjee, and S Sethi, and G Dan, and I Xess
December 2018, Clinical nephrology,
B R Mirdha, and T Sarkar, and U Banerjee, and S Sethi, and G Dan, and I Xess
August 1995, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology,
B R Mirdha, and T Sarkar, and U Banerjee, and S Sethi, and G Dan, and I Xess
April 2024, JPMA. The Journal of the Pakistan Medical Association,
B R Mirdha, and T Sarkar, and U Banerjee, and S Sethi, and G Dan, and I Xess
July 1994, Mycopathologia,
B R Mirdha, and T Sarkar, and U Banerjee, and S Sethi, and G Dan, and I Xess
January 2007, Nihon Jinzo Gakkai shi,
B R Mirdha, and T Sarkar, and U Banerjee, and S Sethi, and G Dan, and I Xess
November 2015, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
B R Mirdha, and T Sarkar, and U Banerjee, and S Sethi, and G Dan, and I Xess
December 1995, The Pediatric infectious disease journal,
B R Mirdha, and T Sarkar, and U Banerjee, and S Sethi, and G Dan, and I Xess
June 2003, The Pediatric infectious disease journal,
Copied contents to your clipboard!